PURPOSE: Vertebral body defects represent one of the most common orthopedic challenges. In order to advance the transfer of stem cell therapies into orthopedic clinical practice, we performed this study to evaluate the safety and efficacy of a composite bioartificial graft based on a hydroxyapatite bone scaffold (CEM-OSTETIC(®)) combined with human mesenchymal stem cells (MSCs) in a rat model of vertebral body defects. METHODS: Under general isoflurane anesthesia, a defect in the body of the L2 vertebra was prepared and left to heal spontaneously (group 1), implanted with scaffold material alone (group 2), or implanted with a scaffold together with 0.5 million MSCs (group 3) or 5 million MSCs (group 4). The rats were killed 8 weeks after surgery. Histological and histomorphometrical evaluation of the implant as well as micro-CT imaging of the vertebrae were performed. RESULTS: We observed a significant effect on the formation of new bone tissue in the defect in group 4 when compared to the other groups and a reduced inflammatory reaction in both groups receiving a scaffold and MSCs. We did not detect any substantial pathological changes or tumor formation after graft implantation. CONCLUSIONS: MSCs in combination with a hydroxyapatite scaffold improved the repair of a model bone defect and might represent a safe and effective alternative in the treatment of vertebral bone defects.
PURPOSE:Vertebral body defects represent one of the most common orthopedic challenges. In order to advance the transfer of stem cell therapies into orthopedic clinical practice, we performed this study to evaluate the safety and efficacy of a composite bioartificial graft based on a hydroxyapatite bone scaffold (CEM-OSTETIC(®)) combined with human mesenchymal stem cells (MSCs) in a rat model of vertebral body defects. METHODS: Under general isoflurane anesthesia, a defect in the body of the L2 vertebra was prepared and left to heal spontaneously (group 1), implanted with scaffold material alone (group 2), or implanted with a scaffold together with 0.5 million MSCs (group 3) or 5 million MSCs (group 4). The rats were killed 8 weeks after surgery. Histological and histomorphometrical evaluation of the implant as well as micro-CT imaging of the vertebrae were performed. RESULTS: We observed a significant effect on the formation of new bone tissue in the defect in group 4 when compared to the other groups and a reduced inflammatory reaction in both groups receiving a scaffold and MSCs. We did not detect any substantial pathological changes or tumor formation after graft implantation. CONCLUSIONS: MSCs in combination with a hydroxyapatite scaffold improved the repair of a model bone defect and might represent a safe and effective alternative in the treatment of vertebral bone defects.
Authors: X S Zhu; Z M Zhang; H Q Mao; D C Geng; J Zou; G L Wang; Z G Zhang; J H Wang; L Chen; H L Yang Journal: J Mater Sci Mater Med Date: 2010-12-03 Impact factor: 3.896
Authors: Jiří Růžička; Nataliya Romanyuk; Aleš Hejčl; Miroslav Vetrík; Martin Hrubý; Graham Cocks; Jiří Cihlár; Martin Přádný; Jack Price; Eva Syková; Pavla Jendelová Journal: Acta Neurobiol Exp (Wars) Date: 2013 Impact factor: 1.579
Authors: Hideo Kobayashi; Takaaki Fujishiro; Stephen M Belkoff; Naomi Kobayashi; A Simon Turner; Howard B Seim; Joseph Zitelli; Monica Hawkins; Thomas W Bauer Journal: J Biomed Mater Res A Date: 2009-03-15 Impact factor: 4.396
Authors: Lukáš Školoudík; Viktor Chrobok; Zuzana Kočí; Jiří Popelář; Josef Syka; Jan Laco; Alžběta Filipová; Eva Syková; Stanislav Filip Journal: Stem Cell Rev Rep Date: 2018-12 Impact factor: 5.739
Authors: Dmitriy Sheyn; Galina Shapiro; Wafa Tawackoli; Douk Soo Jun; Youngdo Koh; Kyu Bok Kang; Susan Su; Xiaoyu Da; Shiran Ben-David; Maxim Bez; Eran Yalon; Ben Antebi; Pablo Avalos; Tomer Stern; Elazar Zelzer; Edward M Schwarz; Zulma Gazit; Gadi Pelled; Hyun M Bae; Dan Gazit Journal: Mol Ther Date: 2015-11-20 Impact factor: 11.454
Authors: Ahmad Jabir Rahyussalim; Ahmad Nugroho; Muhammad Luqman Labib Zufar; Irfan Fathurrahman; Tri Kurniawati Journal: Stem Cells Int Date: 2021-08-23 Impact factor: 5.443
Authors: Pavel Šponer; Stanislav Filip; Tomáš Kučera; Jindra Brtková; Karel Urban; Vladimír Palička; Zuzana Kočí; Michael Syka; Aleš Bezrouk; Eva Syková Journal: Biomed Res Int Date: 2016-04-07 Impact factor: 3.411
Authors: Ahmad Jabir Rahyussalim; Muhammad Deryl Ivansyah; Ahmad Nugroho; Rio Wikanjaya; Anissa Feby Canintika; Tri Kurniawati Journal: Int J Surg Case Rep Date: 2019-12-12